Long term clinical and functional venous outcomes after endovascular transvenous femoro-popliteal bypass

Rumba, Roberts; Krieviņš, Dainis; Savlovskis, Janis; Ezite, Natalija; Kukulis, I.; Petrošina, Eva; Mouttet, Ludovic; Lacis, Aigars; Zarins, Christofer K

doi:10.23736/s0392-9590.22.04937-9

Cited by 2 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, venous system anatomical and functional data were also documented using plethysmography. Venous system parameters and outcomes have been reported recently [ 6 ].…”

Section: Methodsmentioning

confidence: 99%

“…In an effort to combine the benefits of both methods, a new percutaneous endovascular transvenous femoropopliteal bypass technique (also known as the Detour procedure, invented by the company, PQ Bypass) was introduced. This relatively new approach appears to be safe with regards to the venous system [ 6 , 7 ], but the mid-term and long-term patency rates remain to be evaluated. Therefore, the focus of this study was to assess primary, primary-assisted, and secondary bypass patency after transvenous bypass to determine durability of the arterial conduit and the necessity for secondary procedures.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background and Objectives: Peripheral artery disease is one of the most common vascular pathologies. There is an ongoing debate among specialists on whether open or endovascular revascularization is preferred in cases of complex superficial femoral artery (SFA) lesions. The purpose of this study was to assess patency results of a relatively new transvenous endovascular bypass device. This could add to existing evidence and aid in comparison between open and endovascular bypass. Materials and Methods: Patients with complex TASC-C and D SFA lesions who had indications for revascularization were identified. Prospective analysis of stent graft patency from 54 transvenous femoropopliteal bypass procedures was performed. Patency was assessed by Duplex ultrasound every six months. Kaplan–Meier analysis was performed to assess primary, primary-assisted, and secondary patency of transvenous bypass. Results: Following endovascular transvenous femoropopliteal bypass, 3-year graft primary, primary-assisted, and secondary patency was 43.8%, 66.3%, and 73.9%, respectively. Conclusions: Transvenous endovascular femoropopliteal bypass is a viable option for selected patients who lack adequate saphenous vein or have comorbidities that increase the risk of open femoropopliteal bypass. Strict post-operative follow-up is necessary to improve patency rates.

show abstract

“…In addition, venous system anatomical and functional data were also documented using plethysmography. Venous system parameters and outcomes have been reported recently [ 6 ].…”

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%